153 related articles for article (PubMed ID: 27697674)
1. Levels of the soluble LDL receptor-relative LR11 decrease in overweight individuals with type 2 diabetes upon diet-induced weight loss.
Berk KA; Vongpromek R; Jiang M; Schneider WJ; Timman R; Verhoeven AJ; Bujo H; Sijbrands EJ; Mulder MT
Atherosclerosis; 2016 Nov; 254():67-72. PubMed ID: 27697674
[TBL] [Abstract][Full Text] [Related]
2. Circulating soluble form of LR11, a regulator of smooth muscle cell migration, is a novel marker for intima-media thickness of carotid arteries in type 2 diabetes.
Jin W; Jiang M; Han X; Han X; Murano T; Hiruta N; Ebinuma H; Piao L; Schneider WJ; Bujo H
Clin Chim Acta; 2016 Jun; 457():137-41. PubMed ID: 27095609
[TBL] [Abstract][Full Text] [Related]
3. LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients.
Vongpromek R; Bujo H; Hoekstra M; Schneider WJ; van der Zee L; Schinkel AF; Korporaal SJ; Dik WA; Ebinuma H; Jiang M; Verhoeven AJ; Sijbrands EJ; Mulder MT
Atherosclerosis; 2015 Dec; 243(2):429-37. PubMed ID: 26520897
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of measuring soluble LR11, a circulating marker of atherosclerosis and HbA1c in familial hypercholesterolemia.
Nohara A; Kobayashi J; Kawashiri MA; Tada H; Inazu A; Jiang M; Mabuchi H; Bujo H
Clin Biochem; 2014 Sep; 47(13-14):1326-8. PubMed ID: 24859021
[TBL] [Abstract][Full Text] [Related]
5. Enhanced circulating soluble LR11 in patients with diabetic retinopathy.
Takahashi M; Bujo H; Shiba T; Jiang M; Maeno T; Shirai K
Am J Ophthalmol; 2012 Jul; 154(1):187-92. PubMed ID: 22541650
[TBL] [Abstract][Full Text] [Related]
6. Diet-induced weight loss and markers of endothelial dysfunction and inflammation in treated patients with type 2 diabetes.
Berk KA; Oudshoorn TP; Verhoeven AJM; Mulder MT; Roks AJM; Dik WA; Timman R; Sijbrands EJG
Clin Nutr ESPEN; 2016 Oct; 15():101-106. PubMed ID: 28531772
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease.
Ogita M; Miyauchi K; Kasai T; Tsuboi S; Wada H; Naito R; Konishi H; Dohi T; Tamura H; Okazaki S; Yanagisawa N; Shimada K; Suwa S; Jiang M; Bujo H; Daida H
Atherosclerosis; 2016 Jan; 244():216-21. PubMed ID: 26687467
[TBL] [Abstract][Full Text] [Related]
8. Levels of circulating soluble LR11, a regulator of smooth muscle cell migration, are highly associated with atherosclerotic plaques in patients with carotid artery stenosis.
Harada M; Jiang M; Terai K; Ebinuma H; Hiruta N; Schneider WJ; Sugo N; Nagao T; Bujo H
Clin Chim Acta; 2019 Mar; 490():69-76. PubMed ID: 30550937
[TBL] [Abstract][Full Text] [Related]
9. Soluble LR11 associates with aortic root calcification in asymptomatic treated male patients with familial hypercholesterolemia.
Vongpromek R; Bos S; Ten Kate GR; Bujo H; Jiang M; Nieman K; Schneider W; Roeters van Lennep JE; Verhoeven AJM; Sijbrands EJG; Mulder MT
Atherosclerosis; 2017 Oct; 265():299-304. PubMed ID: 28637586
[TBL] [Abstract][Full Text] [Related]
10. Soluble LR11 is a novel biomarker for vascular lesions late after Kawasaki disease.
Watanabe K; Suzuki H; Jiang M; Haniu H; Numano F; Hoshina S; Saitoh A; Uchiyama M; Bujo H
Atherosclerosis; 2016 Mar; 246():94-7. PubMed ID: 26761773
[TBL] [Abstract][Full Text] [Related]
11. Enhanced circulating soluble LR11 in patients with coronary organic stenosis.
Takahashi M; Bujo H; Jiang M; Noike H; Saito Y; Shirai K
Atherosclerosis; 2010 Jun; 210(2):581-4. PubMed ID: 20047743
[TBL] [Abstract][Full Text] [Related]
12. The effect of diet-induced weight loss on circulating homocysteine levels in people with obesity and type 2 diabetes.
Al Fatly M; Mulder MT; Roeters van Lennep J; Blom HJ; Berk KAC
Nutr J; 2024 Jan; 23(1):2. PubMed ID: 38167024
[TBL] [Abstract][Full Text] [Related]
13. Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma.
Fujimura K; Ebinuma H; Fukamachi I; Ohwada C; Kawaguchi T; Shimizu N; Takeuchi M; Sakaida E; Jiang M; Nakaseko C; Bujo H
Clin Chim Acta; 2014 Mar; 430():48-54. PubMed ID: 24394293
[TBL] [Abstract][Full Text] [Related]
14. Association of Weight Loss Maintenance and Weight Regain on 4-Year Changes in CVD Risk Factors: the Action for Health in Diabetes (Look AHEAD) Clinical Trial.
Wing RR; Espeland MA; Clark JM; Hazuda HP; Knowler WC; Pownall HJ; Unick J; Wadden T; Wagenknecht L;
Diabetes Care; 2016 Aug; 39(8):1345-55. PubMed ID: 27271190
[TBL] [Abstract][Full Text] [Related]
15. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials.
Franz MJ; Boucher JL; Rutten-Ramos S; VanWormer JJ
J Acad Nutr Diet; 2015 Sep; 115(9):1447-63. PubMed ID: 25935570
[TBL] [Abstract][Full Text] [Related]
16. Development of an immunoassay for the quantification of soluble LR11, a circulating marker of atherosclerosis.
Matsuo M; Ebinuma H; Fukamachi I; Jiang M; Bujo H; Saito Y
Clin Chem; 2009 Oct; 55(10):1801-8. PubMed ID: 19661140
[TBL] [Abstract][Full Text] [Related]
17. Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes.
Gummesson A; Nyman E; Knutsson M; Karpefors M
Diabetes Obes Metab; 2017 Sep; 19(9):1295-1305. PubMed ID: 28417575
[TBL] [Abstract][Full Text] [Related]
18. Soluble LR11 competes with amyloid β in binding to cerebrospinal fluid-high-density lipoprotein.
Yano K; Hirayama S; Misawa N; Furuta A; Ueno T; Motoi Y; Seino U; Ebinuma H; Ikeuchi T; Schneider WJ; Bujo H; Miida T
Clin Chim Acta; 2019 Feb; 489():29-34. PubMed ID: 30448281
[TBL] [Abstract][Full Text] [Related]
19. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.
Hollander PA; Elbein SC; Hirsch IB; Kelley D; McGill J; Taylor T; Weiss SR; Crockett SE; Kaplan RA; Comstock J; Lucas CP; Lodewick PA; Canovatchel W; Chung J; Hauptman J
Diabetes Care; 1998 Aug; 21(8):1288-94. PubMed ID: 9702435
[TBL] [Abstract][Full Text] [Related]
20. Effects of a monounsaturated fatty acid-enriched hypocaloric diet on cardiovascular risk factors in obese patients with type 2 diabetes.
Gumbiner B; Low CC; Reaven PD
Diabetes Care; 1998 Jan; 21(1):9-15. PubMed ID: 9538963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
